Gujarat Exclusive > National-World > 5 more companies to make medicines for mucormycosis: Mansukh Mandaviya

5 more companies to make medicines for mucormycosis: Mansukh Mandaviya

0
265

Union minister of state for chemicals and fertilisers Mansukh Mandaviya on Thursday said that the shortage of medicines required for treating mucormycosis will be resolved soon.

The minister revealed that five more pharma companies have been provided the approval for the manufacturing of Amphotericin B. This is apart from the six companies that are already manufacturing it.

The companies that have been permitted for manufacturing the medicine include Emcure Pharmaceuticals, Natco Pharma, Gufic Biosciences Limited, Alembic Pharmaceuticals and Lyca Pharmaceuticals. The six companies that are already manufacturing the medicine include Mylan, Bharat Serums, BDR Pharma, Sun Pharma, Cipla and Life Care.

Mandaviya, in a tweet, said, “Black fungus (mucormycosis) curing drug #AmphotericinB ‘s shortage will be resolved soon! Within three days, 5 more Pharma companies have got New Drug Approval for producing it in India, in addition to the existing 6 pharma companies.”

Also Read: 4 held in Ahmedabad for black marketing of injections for mucormycosis

“The existing pharma companies have already started ramping up the production. Indian Companies have also placed orders for importing 6 lakh vials of #AmphotericinB. We are leaving no stone unturned to smoothen the situation,” he added.

Declare mucormycosis an epidemic

 With cases of mucormycosis or black fungus being reported from various states across the country, the Union government has directed all states to declare the fungal infection an epidemic and list it under the Epidemic Diseases Act. States such as Rajasthan and Telangana have already declared the rare but fatal fungal infection as epidemic.

Declaration of disease as epidemic essentially means that all conformed or suspected cases of the disease anywhere in India will have to be reported to the state government and the Union health ministry.

Cases of mucormycosis, a rare fungal infection, are being reported among COVID patients who were administered steroids to treat symptoms, and particularly among those who are suffering from diabetes and cancer. Medical experts have pointed to strong links between diabetes and infection. The disease, which can lead to blackening or discolouration over the nose, blurred or double vision, chest pain, breathing difficulties and coughing blood, is strongly linked to diabetes.

 

To read the latest news in Gujarati click here